BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Wu F, Li L, Lynch EC, Xie L, Zhao Y, Fang K, Li J, Luo J, Xu L, Zou X, Lu F, Chen G. Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation. Phytother Res 2021;35:297-310. [PMID: 32776627 DOI: 10.1002/ptr.6800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Youns M, Askoura M, Abbas HA, Attia GH, Khayyat AN, Goda RM, Almalki AJ, Khafagy ES, Hegazy WAH. Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation. Onco Targets Ther 2021;14:3849-60. [PMID: 34194230 DOI: 10.2147/OTT.S313933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xu S, Feng Y, He W, Xu W, Xu W, Yang H, Li X. Celastrol in metabolic diseases: Progress and application prospects. Pharmacol Res 2021;167:105572. [PMID: 33753246 DOI: 10.1016/j.phrs.2021.105572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Tao W, Hu Y, Chen Z, Dai Y, Hu Y, Qi M. Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2/HO-1/NLRP3 signaling pathway. Phytomedicine 2021;91:153692. [PMID: 34411834 DOI: 10.1016/j.phymed.2021.153692] [Reference Citation Analysis]
4 Li M, Xie F, Wang L, Zhu G, Qi LW, Jiang S. Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms. Front Pharmacol 2022;13:857956. [PMID: 35444532 DOI: 10.3389/fphar.2022.857956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu S, Lyu L, Zhu H, Huang X, Xu W, Xu W, Feng Y, Fan Y. Serum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations. J Proteome Res 2021;20:4840-51. [PMID: 34530620 DOI: 10.1021/acs.jproteome.1c00513] [Reference Citation Analysis]
6 Spano M, Di Matteo G, Ingallina C, Ambroselli D, Carradori S, Gallorini M, Giusti AM, Salvo A, Grosso M, Mannina L. Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation. Nutrients 2022;14:490. [DOI: 10.3390/nu14030490] [Reference Citation Analysis]
7 Chang YH, Hung HY. Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review. Eur J Med Chem 2022;237:114405. [PMID: 35489224 DOI: 10.1016/j.ejmech.2022.114405] [Reference Citation Analysis]